|
08:30-10:00 |
Keynote Lectures
Advances in Obstetrics, Gynecology and Infertility: Leaders' Views on the Future |
|
Capsule |
What does the future hold for our main subdisciplines?
|
| Chairpersons |
Z. Ben-Rafael, Israel
V. Gomel, Canada
G.C. Di Renzo, Italy
|
| 08:30-09:00 |
Fetomaternal Medicine: Intrauterine stem cell transplantation
T-H. Bui, Sweden
|
| 09:00-09:30 |
Gynecology: Surgical approach for endometriosis, do we have limits?
F. Nezhat, USA
|
| 09:30-10:00 |
Infertility & ART:
The Future of In Vitro Maturation (IVM)
R.Fadini, Italy
|
| 10:00-10:30 |
Coffee break
|
|
|
| 10:30-12:30 |
Prevention of Preterm Delivery |
|
Capsule |
Preterm delivery continues to be a major issue in perinatal medicine, yet no effective prevention is available
|
| Chairperson |
G. Sylvestre, USA
|
| 10:30-11:00 |
Should we repeat atosiban tocolysis as frequesntly as required? I. Blickstein, Israel
|
| 11:00-11:30 |
The role of progesterone treatment: Which and how? G.C. Di Renzo, Italy
|
| 11:30-12:00 |
How should a short cervix be managed? I. Wolman, Israel
|
| 12:00-12:30 |
Can nutrition reduce the risk of preterm delivery? P. Lam, China
|
| 12:30-13:30 |
Lunch break
|
|
|
|
13:30-15:30 |
Emergency Situation in Perinatology |
| Capsule |
Life-threatening situation in obstetrics should be identified and treated early
|
| Chairpersons |
I. Blickstein, Israel
R.B. Kalish, USA
|
| 13:30-14:00 |
Uterine atony: What are the most effective steps before hysterectomy?
G.H. Leonard, USA
|
| 14:00-14:30 |
Thrombophilia and pregnancy complications: Requiem?
D. Blickstein, Israel
|
| 14:30-15:00 |
Can we save patients with amniotic fluid embolism?
G.H. Leonard, USA
|
| 15:00-15:30 |
Optimal management of placenta accreta
|
| 15:30-16:00 |
Coffee break
|
|
|
|
16:00-18:00 |
Hot Controversies - Expert Opinion on:
Intrapartum Surveillance |
| Capsule |
Is it possible to minimize the risk of intrapartum asphyxia?
|
| Chairpersons |
G.C. Di Renzo, Italy
A. Antsaklis, Greece
|
|
Discussants |
X. Carbonell-Estrany, Spain M. Carrapato, Portugal I. Blickstein, Israel R.B. Kalish, USA
H. Divakar, India |
|
Questions
|
|
Saturday, November 14, 2009
|
|
|
|
08:30-10:00 |
Early Screening for Nuchal Thickness (NT) |
| Capsule |
NT is a cornerstone in early detection of anomalies; however, confusion exists regarding the next step in increased NT
|
| Chairpersons |
X. Carbonell-Estrany, Spain G.H. Leonard, USA
|
| 08:30-09:30 |
Debate
Proposition: Chorionic villus sampling (CVS) is the next step following increased NT T-H Bui, Sweden Opposition: CVS should be performed only if detailed screening for anomalies is negative Z. Weiner, Israel |
|
09:30-10:00 |
Can we agree on the definition of Dandy-Walker syndrome in ultrasonography? Y. Zalel, Israel
|
| 10:00-10:30 |
Coffee break
|
|
|
|
10:30-12:30 |
Hot Controversies - Expert Opinion on:
Ultrasound (US) Screening for Anomalies |
| Capsule |
Screening for anomalies with US is widely used, however many parts of the examination remain controversial
|
| Chairperson |
T-H Bui, Sweden
|
|
Discussants |
Z. Weiner, Israel G. Sylvestre, USA Y. Zalel, Israel A. Antsaklis, Greece |
|
Questions
|
| 12:30-13:30 |
Lunch break
|
|
|
|
13:30-15:30 |
US Screening for Anomalies II |
| Capsule |
Cardiac anomalies can affect 1:200 low-risk patients; however, current recommendations are that only high-risk cases be screened. Are these valid?
|
| Chairpersons |
X. Carbonell-Estrany, Spain
R.B. Kalish, USA
|
| 13:30-14:30 |
Debate
Proposition: Guidelines usually recommend that an echocardiogram be performed in high-risk cases, and between 18 and 20 weeks Y. Zalel, Israel Opposition: An echocardiogram should be performed in all low-risk patients, and 99% can already be identified at 12-16 weeks! Z. Weiner, Israel |
|
14:30-15:00 |
Screening by US in perinatal medicine A. Antsaklis, Greece
|
|
15:00-15:30 |
What are the traps and tricks in performing "four chamber views"? Y. Zalel, Israel
|
| 15:30-16:00 |
Coffee break
|
|
|
|
16:00-18:00 |
Complications of Pregnancy: Pre-eclampsia |
| Capsule |
Can we decrease mortality and morbidity through early diagnosis and treatment of pre-eclampsia?
|
| Chairpersons |
A. Antsaklis, Greece E. Schiff, Israel
|
| 16:00-16:30 |
Controversies regarding late offspring outcome of mothers with pre-eclampsia
|
| 16:30-17:00 |
Can we predict or prevent pre-eclampsia? E. Schiff, Israel
|
| 17:00-17:30 |
Can we manage pre-eclampsia effectively without knowing the pathophysiology? TBA
|
| 17:30-18:00 |
Angiogenic biomarkers for pre-eclampsia W.W. Sumpaico, Philippines
|
| 18:30-20:00 |
"Voices" Special Entertainmetn Lecture by Dr. C.O. (Skip) Granai, USA |
|
Sunday, November 15, 2009
|
|
|
| 08:30-10:00 |
Complications of Pregnancy I |
| Capsule |
The SEA perspectives on medical complications of pregnancy Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG)
|
| Chairperson |
W.W. Sumpaico, Philippines
G. Sylvestre, USA
|
| 08:30-08:52 |
Where have we gone wrong in obstetric sonography and prenatal diagnosis?
C. Anandakumar, Singapore
|
| 08:52-09:14 |
How does gestational anemia affect Generation next? H. Divakar, India
|
| 09:14-09:36 |
How can we deal with gestational diabetes mellitus (GDM) in low-resource settings? U. Thanawala, India
|
| 09:36-10:00 |
Screening for thyroid dysfunction in pregnancy: The South Asian perspective W.W. Sumpaico, Philippines
|
| 10:00-10:30 |
Coffee break
|
|
|
| 10:30-12:30 |
Complications of Pregnancy II |
| Capsule |
Recent studies claim that vaginal breech delivery is unsafe: Lack of experienced obstetricians supports the conclusion
|
| Chairpersons |
E. Schiff, Israel
|
| 10:30-11:15 |
Debate
The Breech Debate: It is Proven Beyond any Doubt that Vaginal Breech Delivery is Unsafe
Proposition: Vaginal breech delivery is unsafe! All term breeches should be delivered by elective Caesarean section G. Sylvestre, USA / R.B. Kalish, USA Opposition: Singleton vaginal breech delivery at term: Still a safe option
I. Blickstein, China
|
|
11:15-11:45 |
External cephalic version in modern obstetrics: Risks vs. benefits? R.B. Kalish, USA
|
| 11:45-12:30 |
Debate
Are Twins Really an Adverse Outcome in IVF? Yes: I. Blickstein, Israel No: N. Gleicher, USA |
|
|
|